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Little information is available about the management of adrenalectomies in 
veterinary anaesthesia. The aim of this study was to describe the anaesthetic tech-
niques, the complication rate and outcome of these cases. Data were collected ret-
rospectively from patients’ records. Descriptive statistics were performed with 
Student’s t-tests and Chi-square tests where appropriate. Forty-one cases were in-
cluded. The mean age was 124.7 ± 29.4 months and the median body weight was 
23.1 kg (5.3–69 kg). Carcinoma was the most common diagnosis (34.1%). Pre-
medication was most commonly achieved with methadone alone (70.7%) IV. 
Propofol was the most common induction agent (39%). An infusion of opioids 
(80.4%) and an epidural injection of morphine (70.7%) were the most common 
analgesic techniques. Hypotension was the most common complication observed 
(51.2%). The mortality rate was 14.6%. The lowest recorded oesophageal temper-
ature was statistically associated with the incidence of haemorrhage (P = 0.025). 
The invasion of the vena cava (P = 0.001) was significantly associated with 
haemorrhagic complications. The survival rate was better when patients received 
hydrocortisone intra-operatively (P = 0.026). This study highlights some possible 
association between the anaesthetic management and the outcome of the proce-
dure. 
Key words: Anaesthesia, canine, adrenalectomies, complications, hydro-
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Primary adrenal gland tumours are rare in dogs (0.17% to 0.76%) (Massari 
et al., 2011) and surgical resection can be challenging. The perioperative compli-
cation rate can be as high as 51% in some studies (Kyles et al., 2003) with the 
mortality rate ranging between 13.5% and 60%, the latter when including cases 
euthanised intra-operatively (Scavelli et al., 1986; Massari et al., 2011). These 
mortality rates have been improved following the introduction of new protocols 
for pre- and perioperative management. For example, the use of phenoxyben-
zamine preoperatively has been shown to decrease mortality from 48 to 13% 
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(Herrera et al., 2008) when given for a median of 20 days prior to the removal of 
a phaeochromocytoma. 
Despite several publications on this subject, little attention has been given 
to the anaesthetic and analgesic management of those cases in veterinary medi-
cine. Detailed descriptions of anaesthetic and analgesic protocols or the treatment 
of intra-operative complications are lacking in the majority of adrenalectomy 
studies. To our knowledge, there has been no evaluation of different anaesthetic 
or analgesic protocols with regards to their efficacy or the incidence of complica-
tions or survival. Thus, the objective of this study was to evaluate the anaesthetic 
management of adrenalectomies at a single academic centre over ten years. 
The primary aim was to describe the anaesthetic and analgesic protocols, 
the encountered complications rate and the outcome. The secondary aim was to 
evaluate associations between preoperative conditions, anaesthetic or analgesic 
drugs and complications during the surgery or outcome. 
 
 
Materials and methods 
Case collection 
An electronic database of all surgical cases admitted to the Royal Veteri-
nary College was searched with the key word ‘adrenal’ to find potential candi-
dates for inclusion in the study. The database was available between October 
2007 and June 2017. Cases were selected if a unilateral or bilateral adrenalecto-
my was performed. Medical records were consulted to find the relevant medical 
history, demographic information, and the anaesthetic record of the procedure. 
Cases were excluded if the anaesthetic record was missing or incomplete with 
regards to the anaesthetic protocol used. 
Ethics approval was given by the Clinical Research Ethical Review Board 
under the number 2017 1692-1. 
Data collected were breed, age in months, sex, weight, side of the tumour, 
invasion of the vena cava, drugs used for premedication, induction, analgesia and 
maintenance of anaesthesia, surgical time, anaesthetic time, use of vasopressors 
or positive inotropes, use of phentolamine, use of hydrocortisone, use of pre-
operative phenoxybenzamine, histological diagnosis, cardiovascular parameters 
(heart rate, arterial blood pressure), lowest oesophageal temperature, and compli-
cations under general anaesthesia. The complications recorded were defined as 
follows: 
• Arrhythmia: any deviation from sinus rhythm mentioned on the anaes-
thetic record. 
• Haemorrhage: any blood loss mentioned on the anaesthetic record. 
• Hypertension: any measurement of the systolic blood pressure (SBP) 
above 180 mmHg when measured via an arterial catheter (invasive blood 
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pressure, IBP) or a Doppler or any measurement of the mean blood pres-
sure (MBP) above 120 mmHg when measured with an oscillometric 
technique. 
• Hypotension: any measurement of MBP lower than 60 mmHg for more 
than 5 min if IBP or an oscillometric technique was used or SBP lower 
than 80 mmHg if a Doppler was used.  
• Death: any death or euthanasia occurring under anaesthesia or postop-
eratively within the first 72 h due to deteriorating clinical conditions 
and lack of improvement.  
 
Continuous data were tested for normality with a Shapiro–Wilk test. Nor-
mally distributed variables were described with their mean and standard deviation 
(SD). Median, minimum and maximum values were used for non-normally dis-
tributed data. Qualitative data were described with frequencies and percentages. 
Comparison of continuous variables between two groups was performed with Stu-
dent t-tests for normally distributed data or Mann–Whitney U-tests for non-
normally distributed data. Comparison of qualitative data was performed with Chi-
square tests or Fisher exact tests where applicable. For variables that displayed 
more than two modalities (e.g., histological diagnosis) and for which the number 
of observations per modality was low, some of those modalities were grouped in 
order to perform comparisons between two groups only (e.g., phaeochromocyto-
mas vs. non-phaeochromocytomas). Cases where the data relevant to the compari-
son performed was missing or unknown were not included. The level of signifi-
cance was set at 5% (P < 0.05). 
 
Results 
Between November 2007 and June 2017, 57 cases of adrenalectomies 
were identified. These included four cats that were not included in the study. Af-
ter application of inclusion and exclusion criteria, 41 cases were kept for analy-
sis. All surgeries were performed by board-certified surgeons or supervised resi-
dents. All cases were anaesthetised by supervised anaesthesia residents or board-
certified anaesthetists. 
There were 22 females (22/41, 53.6%) and 19 males (19/41, 46.3%). 
Breeds included crossbreed (6 cases), Labrador, Lurcher (3 cases each), Boxer, 
Yorkshire Terrier, West Highland White Terrier, Staffordshire Bull Terrier, Shih 
Tzu (2 cases each), and 19 other different breeds for each remaining individual. 
Age, surgery time and lowest recorded oesophageal temperature were 
normally distributed. Body weight and anaesthetic time were not normally dis-
tributed (P < 0.05). Mean ± SD age was 124.7 ± 29.4 months, mean ± SD surgi-
cal time was 153.3 ± 13.6 min and mean ± SD lowest recorded oesophageal tem-
perature was 35 ± 1.2 °C. 
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Median (minimum–maximum) anaesthetic time was 235 min (165–470 min) 
and median (minimum–maximum) body weight was 23.1 kg (5.3–69 kg). 
Based on preoperative imaging (abdominal ultrasound and/or computed 
tomography), an adrenal mass or enlargement was present on the right side in 
16/41 cases (39%), on the left side in 24/41 cases (58.5%) and was bilateral in 
1/41 cases (2.4%). The vena cava was invaded in 11/41 cases (26.8%). The type 
of tumour invading the vena cava was a phaeochromocytoma in 8/11 cases and a 
carcinoma in 3/11 cases. 
Pre-operative results of investigations regarding the nature of the adrenal 
mass were available for twenty cases (20/41, 48.8%). Fourteen cases of adrenal-
dependent hyperadrenocorticism were confirmed (14/20) along 6 phaeochromo-
cytomas (6/20). For all remaining cases but five, a definite diagnosis was ob-
tained after histological analysis (Table 1). For those five cases, the histological 
report was non-conclusive regarding the nature of the neoplasia. 
Table 1 
Postoperative histological diagnosis 
Histological type Frequency Percentage 
Adrenal cortical carcinoma 14 34.1 
Phaeochromocytoma 12 29.3 
Adrenal cortical adenoma 7 17.1 
Unknown 5 12.2 
Adrenal cortical hyperplasia 1 2.4 
Suspected phaeochromocytoma 1 2.4 
Haemangiosarcoma 1 2.4 
 
All cases were monitored with the same standard equipment: 3-lead electro-
cardiograph (ECG), capnograph, pulse oximeter, blood pressure monitor (IBP, 
Doppler or oscillometric), oesophageal thermometer, anaesthetic agent and gas an-
alyser. All animals but two had an arterial catheter placed in a dorso-pedal artery 
and 36/41 had a central venous catheter inserted in one of the two jugular veins. 
Anaesthetic protocol 
Premedication. All cases received an opioid, sometimes combined with 
acepromazine (6/41, 14.6%, dose range: 0.005–0.02 mg/kg), medetomidine (3/41,  
7.3%, 0.005 mg/kg intramuscularly) or alfaxalone (1/41, 2.4%, 0.75 mg/kg in-
tramuscularly). The opioid used most commonly was methadone (39/41, 95.1%, 
dose range: 0.1–0.4 mg/kg, intravenously or intramuscularly), used as the sole 
premedication agent in 29/41 cases (70.7%). Other opioids used were morphine 
or pethidine in one case each (1/41, 2.4%). Table 2 summarises the different 
combinations used for premedication. 
286 MERLIN and VERES-NYÉKI 
Acta Veterinaria Hungarica 67, 2019 
Table 2 
Drug combinations used for premedication 
Drug combination Frequency Percentage 
Methadone alone  
(0.1 mg/kg intramuscularly – 0.4 mg/kg intramuscularly) 29 70.7 
Acepromazine  
(0.005 – 0.02 mg/kg) + Methadone (0.2 – 0.3 mg/kg) 6 14.6 
Medetomidine  
(0.001 intravenously – 0.005 intramuscularly mg/kg) +  
Methadone (0.2 – 0.3 mg/kg intramuscularly) 3 7.3 
Alfaxalone  
(0.75 mg/kg intramuscularly) +  
Methadone (0.3 mg/kg intramuscularly) 1 2.4 
Morphine (0.2 mg/kg intravenously) 1 2.4 
Pethidine 1 2.4 
 
Induction. The most commonly used agent for induction of anaesthesia was 
propofol (30/41, 73.1%) either alone or combined to a benzodiazepine (14/30). 
Alfaxalone was used in six cases (6/41, 14.6%). Benzodiazepines were used for 
23 cases in total and were either diazepam in three cases (3/23) or midazolam in 
20 cases (20/23). Fentanyl was used as an induction agent in 3/41 cases (7.3%) 
always in combination with midazolam. Propofol and midazolam were combined 
with lidocaine (1–2 mg/kg intravenously) in two cases. Other combinations and 
drugs are reported in Table 3. 
Table 3 
Drug combinations used for induction 
Drug combination Frequency Percentage 
Propofol alone 16 39 
Propofol + Midazolam (0.2–0.5 mg/kg) 9 21.9 
Alfaxalone + Midazolam (0.3–0.4 mg/kg) 4 9.8 
Fentanyl  
(0.005–0.01 mg/kg intravenously) + Midazolam (0.2–0.5 mg/kg) 
 
3 
 
7.3 
Propofol + Diazepam (0.2–0.4 mg/kg) 3 7.3 
Alfaxalone 2 4.8 
Etomidate + Midazolam 2 4.8 
Propofol + Midazolam (0.2–0.5 mg/kg) + Lidocaine (1–2 mg/kg) 2 4.8 
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Maintenance. Isoflurane was used in 27/41 (65.9%) cases and sevoflurane 
in 14/41 (34.1%) cases. 
Analgesic protocol 
Table 4 summarises the different drugs used for analgesia and Table 5 
their combinations. The opioid used in the CRI was fentanyl (dose range: 0.05–
0.4 µg/kg/min) in 28 cases (28/41, 68.3%), remifentanil (dose range: 0.1–0.3 µg/ 
kg/min) in four cases (4/41, 9.8%) and morphine (0.1 mg/kg/h) in one case. 
Table 4 
Drugs used for analgesia. Total number of cases and sum of percentages are above 100% due to 
combinations (see Table 5) 
Analgesic drug and dose range when available Frequency Percentage 
Constant Rate Infusion (CRI) of opioids 33 80.4 
Morphine epidural (0.1–0.2 mg/kg) 29 70.7 
Lidocaine CRI (30–60 µg/kg/min) 7 17.1 
Ropivacaine epidural (1 mg/kg in 0.2 mL/kg;  
0.5 mg/kg in 0.3 mL/kg; high epidural L1–L2 with 0.1 mL/kg) 3 7.3 
Transverse abdominis plane (TAP) block  
(maximum dose 2 mg/kg diluted) 3 7.3 
Local instillation of ropivacaine  
(maximum dose calculated 1.5 mg/kg) 2 4.9 
Ultrasound-guided paravertebral block 2 4.9 
Ketamine (0.5 mg/kg single injection) 1 2.4 
Nitrous oxide (inspired fraction: 50–66%) 1 2.4 
Other perioperative drugs 
As part of the preoperative management of suspected phaeochromocyto-
mas, 17/41 dogs received phenoxybenzamine prior to surgery (0.3–0.9 mg/kg; 
frequency of administration and duration of treatment prior to surgery not avail-
able). All twelve cases of phaeochromocytomas were treated preoperatively with 
phenoxybenzamine and in six cases this treatment was initiated following a pre-
operative diagnosis. The remaining six phaeochromocytomas and the five other 
cases that received phenoxybenzamine prior to the surgery were pre-treated on 
the basis of a clinical suspicion. 
Patients who had a confirmed diagnosis of hyperadrenocorticism prior to 
the surgery (14 cases) were treated with trilostane in five cases (dose and dura-
tion of the treatment not available). All patients who had a hyperadrenocorticism 
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confirmed prior to the surgery received a constant rate infusion of hydrocortisone 
under general anaesthesia (0.5 mg/kg/hour started 1 h before induction and con-
tinued 12 to 24 h postoperatively). Some cases received hydrocortisone in the 
absence of pre-operative hyperadrenocorticism (including six undiagnosed phae-
ochromocytomas). In total 24/41 cases received a hydrocortisone CRI and one dog 
received an infusion of dexamethasone over 4 h (total dose administered 0.5 mg/kg) 
under general anaesthesia. 
Table 5 
Drug combinations used for analgesia 
Analgesic combination Frequency Percentage 
Fentanyl CRI + Morphine epidural 14 34.1 
Fentanyl CRI 5 12.2 
Methadone (premedication) + Morphine epidural +  
Ropivacaine epidural 3 7.3 
Remifentanil CRI + Morphine epidural 3 7.3 
Fentanyl CRI + Lidocaine CRI 2 4.9 
Fentanyl CRI + Lidocaine CRI + Morphine epidural 2 4.9 
Fentanyl CRI + Morphine epidural + Local ropivacaine 2 4.9 
Fentanyl CRI + Lidocaine CRI + Morphine epidural +  
Nitrous oxide 1 2.4 
Fentanyl CRI + Morphine epidural + TAP block 1 2.4 
Fentanyl CRI + TAP block 1 2.4 
Methadone (premedication + bolus) + Lidocaine CRI 1 2.4 
Methadone (premedication) + Fentanyl boluses +  
Paravertebral block 1 2.4 
Methadone (premedication) + Paravertebral block (T10–T11) 1 2.4 
Morphine epidural + Lidocaine CRI 1 2.4 
Morphine epidural + Morphine CRI + Ketamine 1 2.4 
Morphine epidural + TAP block 1 2.4 
Remifentanil CRI 1 2.4 
 
For cases with an invasion of the vena cava by a thrombus or an extension 
of the tumour, a venotomy was performed (11/41, 26.8%). Unfractionated hepa-
rin was given intravenously (30–50 IU/kg) either before or after the venotomy 
was performed to 8/11 dogs (two carcinomas and six phaeochromocytomas). 
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Complications 
In 30/41 cases (73.1%) at least one perioperative complication was seen. 
Table 6 summarises the different combinations of complications encountered. 
Hypotension was the most common complication observed (21/41, 51.2%) 
and treated at the discretion of the attending anaesthetist. Crystalloid boluses 
were administered in 12/41 cases (29.3%) and colloid boluses in 13/41 cases 
(31.7%, either a gelatine-based or a starch-derived colloid depending on the 
available product). 
Table 6 
Combinations of complications under general anaesthesia 
Complications Frequency Percentage 
Hypertension alone 6 20 
Hypotension alone 6 20 
Hypotension + Haemorrhage 4 13.3 
Hypotension + Arrhythmia 3 10 
Hypotension + Hypertension 3 10 
Hypotension + Hypertension + Haemorrhage 3 10 
Arrhythmia + Hypertension 2 6.6 
Hypotension + Hypertension + Haemorrhage + Arrhythmia 2 6.6 
Haemorrhage alone 1 3.3 
 
Bradycardia was treated with atropine (10–20 µg/kg intravenously) or gly-
copyrrolate (5–10 µg/kg intravenously) in 13 cases (13/41, 31.7%). 
The use of a vasopressor or positive inotrope was recorded in 13/41 cases 
(31.7%). Drugs used were either dopamine (5–10 µg/kg/min intravenously, 9/41 
cases, 21.9%), noradrenaline (0.1–0.2 µg/kg/min intravenously, 2/41 cases, 4.9%), 
phenylephrine as single bolus (3 µg/kg intravenously, 2/41 cases, 4.9%) or as a 
CRI (1–2 µg/kg/min intravenously, 1/41 case, 2.4%) or ephedrine (0.05 mg/kg 
intravenously, 4/41, 9.8%). A combination of those options was used in five cas-
es (5/41, 12.2%). 
Hypertension was reported in 16 cases (16/41, 39%). The exact maximum 
SBP was not always available for analysis as some records only mention spikes 
in HR and BP (above 180 mmHg). When recorded, maximum SBP at the time of 
the hypertensive episode ranged between 190 and 240 mmHg. In the subgroup of 
phaeochromocytomas, 7/12 cases had a hypertensive episode. 
Phentolamine (0.5–3 µg/kg/min ± 0.2–0.5 mg/kg bolus intravenously) was 
used in 7/41 cases (17.1%). Six of those seven cases were confirmed or suspect-
ed phaeochromocytomas and one was a carcinoma. 
Haemorrhage was reported in 10 cases (10/41, 24.4%). In total, 5/41 cases 
(12.2%) received a blood transfusion (10 mL/kg). 
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In one case, the transfusion was started due to an acute haemoabdomen 
which was diagnosed prior to the surgery and the volume lost could not be calcu-
lated. In the other four cases, the transfusion was started due to blood losses during 
the surgery, although only one case had a record of the amount of blood lost (40% 
estimated at the end of the surgery). In the remaining six cases of haemorrhage, the 
volume lost was estimated between 7.6% and 40% of total blood volume. 
Different types of arrhythmias were reported in seven dogs (7/41, 17.1%). 
Ventricular tachycardia and sporadic ventricular premature complexes were re-
ported in three dogs (in one case those arrhythmias were present before induction). 
Two dogs had some episodes of supraventricular tachycardia or atrial premature 
complexes. Finally, one dog had an atrial standstill following the first surgical 
incision and in one dog a temporary sinus arrest was observed followed later dur-
ing the procedure by a temporary depression of the ST segment. This last case 
was receiving a lidocaine infusion when the arrhythmia occurred and was one of 
the two cases of phaeochromocytomas to display some arrhythmic features. The 
atrial standstill responded to the initiation of a phentolamine CRI. As they were 
only temporary and self-resolving, no treatment was recorded in the other cases. 
In four of those seven cases, a history of preoperative arrhythmias was reported. 
Outcome 
Overall, six deaths were recorded during the first three days after the sur-
gery (mortality rate 6/41, 14.6%; three phaeochromocytomas, two carcinomas and 
one haemangiosarcoma). Four of those cases were euthanised, one died during 
the recovery phase and the last one suffered from cardiopulmonary arrest three 
days after the surgery. Only this last animal underwent necropsy but no obvious 
cause for the death was identified (suspected cortical carcinoma, no invasion of 
the vena cava, preoperative history of ventricular arrhythmias and elevated cardi-
ac troponins). 
In three cases (all euthanised between day 2 and day 3 after the surgery), 
animals displayed clinical signs that were deemed compatible with a pulmonary 
thromboembolism (acute onset of tachypnoea, low peripheral haemoglobin oxy-
gen saturation, exclusion of all other possible causes for the observed clinical 
signs, predisposing factors). Two of those cases had a phaeochromocytoma and 
one a cortical carcinoma. Both phaeochromocytoma cases were receiving phe-
noxybenzamine before the surgery due to a high clinical suspicion in the absence 
of a definite diagnosis. All three cases had a venotomy performed and none of 
them received perioperative unfractionated heparin. 
The fourth case euthanised was displaying signs of recurrent untreatable 
postsurgical bleeding probably due to a disseminated intravascular coagulopathy. 
This case had been admitted for a haemoabdomen and the adrenal mass removed 
was a metastasised haemangiosarcoma without any invasion of the vena cava. 
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Finally, the dog that died during recovery had been admitted to surgery for 
the removal of an invading phaeochromocytoma and had been treated with phe-
noxybenzamine for 3 days. A venotomy was performed at a low core tempera-
ture (between 32 and 33 °C) and while closing the abdominal cavity, the blood 
pressure decreased progressively without responding to any vasopressor adminis-
tered until cardiac arrest occurred. 
Statistical analysis 
Continuous variables. The lowest recorded oesophageal temperature was 
statistically associated with the incidence of haemorrhage with a mean (± SD) 
temperature for cases that experienced haemorrhage (10/39 – 25.6%) of 34.3 °C 
± 0.91 versus 35.3 °C ± 1.26 for non-haemorrhagic patients (29/39 – 74.4%) (P = 
0.025). 
Categorical variables. When separating phaeochromocytomas from all 
other types of tumours, male dogs (regardless of their neutering status) were 
overrepresented amongst phaeochromocytoma cases (9/13 – 69.2%) (P = 0.045). 
Phaeochromocytomas invaded the vena cava significantly more (8/11 cases – 
72.7%) than non-phaeochromocytomas (P = 0.001). 
Patients that did not receive hydrocortisone during the procedure (16 cases) 
are overrepresented amongst the non-survivors (5 cases – 83.3% of the total num-
ber of deceased cases) (P = 0.026). 
Three out the six cases (50%) that received alfaxalone died compared to 
3/35 (8.5%) cases that did not receive alfaxalone (P = 0.031). 
 
 
Discussion 
To the authors’ knowledge, this is the first report about adrenalectomies 
primarily focusing on the anaesthetic and analgesic management over 10 years at 
a single institution. 
In agreement with earlier publications, adrenalectomies were performed 
rarely during the study period, mostly on old dogs and there was no predisposition 
of age or breed (van Sluijs et al., 1995; Barthez et al., 1997; Anderson et al., 2001; 
Kyles et al., 2003; Schwartz et al., 2008; Jimenez Pelez et al., 2008; Herrera et al., 
2008; Massari et al., 2011; Lang et al., 2011; Barrera et al., 2013; Naan et al., 
2013) In the present study, the proportion of males affected by phaeochromocyto-
mas was significantly higher, similarly to the findings of Kyles et al. (2003). Car-
cinoma was the predominant type of neoplasia followed by phaeochromocytomas. 
Phaeochromocytomas seemed to invade the vena cava more often than other tu-
mours. There was no statistical association between the type of neoplasia, the sur-
gical time, the anaesthetic time and the incidence of complications as reported be-
fore. (Schwartz et al., 2008; Massari et al., 2011; Lang et al., 2011)  
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The mortality rate in this study (14.6%) was higher than what was report-
ed previously in the general canine population (between 0.17% and 1.35%), even 
when considering only cases with a higher ASA status (1.33% for cases with an 
ASA status of 3 to 5) (Brodbelt, 2009; Bille et al., 2011). Although half of the 
deaths were associated with a phaeochromocytoma, the mortality rate in the pre-
sent study is consistent with the latest publications regarding adrenalectomies in 
general (Lang et al., 2011; Barrera et al., 2013; Naan et al., 2013). One of the 
main difficulties when comparing mortality rates is the consistency of the defini-
tion given to perioperative mortality. We chose to include cases that were eu-
thanised due to the fact that euthanasia was elected because of a clinical deterio-
ration, likely due to the underlying disease and recent surgery, that would have 
probably resulted in death eventually. It could have been interesting to separate 
the morbidity related to an emergency procedure from the morbidity related to 
elective cases. However, as we mentioned previously this information was not 
always available in the dataset and the limited number of deaths recorded would 
probably weaken any statistical association. 
Another finding of this study was the association between the use of alfax-
alone and overall death. Four cases that died in this case series were euthanised 
because of a deterioration in their clinical condition presumably because of pul-
monary thromboembolisms or a disseminated intravascular coagulation and three 
of them received alfaxalone for induction. Although the overall number of cases 
induced with alfaxalone was limited to 6 and thus, the interpretation of this asso-
ciation must be very prudent, this finding is interesting and has never been re-
ported previously to the authors’ knowledge. However, correlation does not nec-
essarily prove an underlying causal relationship and this finding must be re-
evaluated with a larger sample. Alfaxalone is a recent induction agent in the his-
tory of veterinary anaesthesia and is not in use in human medicine at the time of 
writing. No effect on the coagulation cascade has been identified as of yet but 
this may be a finding that could warrant further exploration. 
The use of hydrocortisone was associated with increased survival. As re-
ported, in our population hydrocortisone was systematically used for hyperadre-
nocorticism cases prior to the surgery due to the risk of postoperative adrenal in-
sufficiency. This supplementation was inconsistent in all other cases. However, 
the nature of the tumour had not been determined in all cases prior to the surgical 
intervention. In some instances, potentially steroid-secreting epithelial tumours 
were identified on histopathological examination and would have benefited from 
perioperative steroid supplementation. 
For non-steroid-producing tumours, the perioperative use of corticoids is 
currently poorly described in the literature. In critical illness or following major 
surgery, the endogenous secretion of cortisol will normally increase (Shaikh et 
al., 2012). However, it is difficult to determine pre-operatively whether this re-
sponse will be appropriate in a given patient. Moreover, in human patients chron-
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ic secretion of catecholamines by phaeochromocytomas will tend to down-
regulate adrenergic receptors and removal of the affected gland will abruptly de-
crease the plasmatic levels of circulating catecholamines (Connor and Boumph-
rey, 2016). One of the effect of steroids (endogenous or exogenous) is to increase 
the sensitivity of those receptors to catecholamines (Shaikh et al., 2012). 
Thus, we believe that the association found between the lack of periopera-
tive supplementation with hydrocortisone and death could reflect an unexpected 
state of postoperative hypoadrenocorticism either due to an insufficient endoge-
nous response to the surgical stress, a missed diagnosis of hyperadrenocorticism 
or because of a decreased response to and concentration of endogenous catechol-
amines when considering phaeochromocytomas. 
Haemorrhage was also associated with a lower mean minimal oesophageal 
temperature. This may reflect a deliberate choice from the anaesthetist to achieve 
hypothermia in some cases, but this information was not recorded. Hypothermia 
has been shown to decrease oxygen consumption and minimise organ dysfunc-
tion in the event of low circulation or circulatory arrest, as what may happen dur-
ing occlusion of the venous inflow (Brodeur et al., 2017). However, it may also 
affect the canine coagulation system and promote hypocoagulation, by inhibiting 
the enzymatic coagulation cascade, sequestration of platelets in the spleen and 
the liver and decreased platelet aggregation (Clark-Price, 2015; Sessler, 2016; 
Brodeur et al., 2017). In humans, hypothermia has also directly been associated 
with an increase of 16% in blood losses for each degree below the normal tem-
perature (Rajagopalan et al., 2008). With regard to adrenalectomies, further pro-
spective research should be performed to identify a potential benefit of therapeu-
tic hypothermia when an occlusion of the vena cava needs to be performed. 
In this study, the second most common analgesic treatment administered 
to the patients was an epidural injection of morphine (sometimes combined with 
a local anaesthetic drug). When morphine was used alone, a strong opioid CRI 
was always combined with the epidural, but on the three occasions when ropiva-
caine was injected with the epidural morphine no further opioid than the initial 
methadone for premedication was injected. The analgesic efficacy of preserva-
tive free morphine in the epidural space has been studied in dogs undergoing 
laparotomies and proved to be beneficial (Pekcan and Koc, 2010). In humans, 
there is some evidence that epidural anaesthesia could decrease hypercoagulation 
(Tuman et al., 1991; Williams et al., 1999; Hollmann, 2001) and improve mortal-
ity rates following major vascular surgeries but not necessarily improve morbidi-
ty. In the present study, we did not identify any correlation between the use of an 
epidural and the incidence of complications. Further prospective research on a 
large sample may be warranted to identify a benefit of epidurals on the canine 
coagulation system or in the setting of a major vascular surgery. 
Although it is known that the lack of analgesia can affect the surgical 
prognosis by increasing the stress response, the oxygen consumption, the time to 
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complete wound healing (Wiese and Yaksh, 2015), to date there is no report 
proving that one analgesic technique can affect significantly the prognosis of ex-
ploratory laparotomies in veterinary medicine. In the present study, no associa-
tion between any analgesic drug or combination and one of the studied outcomes 
could be identified. 
Due to the retrospective nature of the study, many different anaesthetic 
and analgesic protocols and combinations were described in this paper. This va-
riety can be explained by the number of different anaesthetists in charge over the 
10 years covered by the study, the availability of different drugs at a certain point 
in time and the description of newer techniques such as the paravertebral or the 
transverse abdominis plane block. It is almost impossible to justify retrospective-
ly the use of one protocol over the other for each case and it is very likely that 
the choice made at the time was based on a combination of personal preference 
for one technique or protocol and the perceived need based on the clinical exam-
ination and planned surgical technique. 
Due to the numerous combinations and parameters included in this study, 
it is possible that the use of repeated univariate tests has led to underpowered 
conclusions. A multivariate analysis would be the step to take if more cases would 
become available for analysis. As mentioned earlier many drugs or combinations 
were used on a small number of individuals and this could create an even bigger 
bias in a multivariate analysis. Therefore, this type of analysis was not performed 
but some significant findings may have been missed. 
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